Latest Valtrex news
Aglatimagene Besadenovec + Valacyclovir Ups DFS in Localized Prostate Cancer
posted June 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
Pritelivir Beats Valacyclovir for Genital HSV-2 Shedding
posted December 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
The novel herpes simplex virus (HSV) helicase-primase inhibitor pritelivir is more effective than valacyclovir for reducing genital HSV-2 shedding, according to a study published in the Dec. 20 issue of the Journal of the American Medical Association.
Editor's Recommendations
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders 
Drug Retention in Spondyloarthritis Varies With Socioeconomic Status 
Chemo-Free Combo of Four Targeted Therapies Shows Promise in Metastatic Breast Cancer 
December 2024 to 2025 Saw Significant Increase in Leucovorin Dispensing Related Articles
Real-World ARIA Incidence With Lecanemab Aligns With Clinical Trial Findings 
Dexrazoxane Offers Lasting Doxorubicin Cardioprotective Effect in Childhood Cancer Survivors 
Many With Atypical Alzheimer Disease Do Not Qualify for Anti-Amyloid Therapy 
Study IDs Neurobiological Roots of Sensory Over-Responsivity Monthly Specialist Briefings
Stay Connected
